EC Number |
Application |
Reference |
---|
3.5.3.18 | medicine |
2-chloroacetamidine may potentially find wide applicability as a general pharmacophore, useful in delineating characteristics of the amidinotransferase superfamily |
664074 |
3.5.3.18 | medicine |
DDAH activity and elevated endogenous asymmetric dimethylarginine is implicated in endothelial dysfunction exposed to glycosylated bovine serum albumin, aminoguanidine can protect endothelium against injury induced by glycosylated bovine serum albumin both in vitro and in vivo |
667365 |
3.5.3.18 | medicine |
DDAH influences insulin sensitivity by regulating the endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine |
695944 |
3.5.3.18 | more |
DDAH1 plays an important role in development |
668120 |
3.5.3.18 | medicine |
decreased DDAH-1 expression may cause accumulation of endogenous inhibitors of enothelial NO synthase, thereby contributing to endothelial dysfunction in the failing heart |
667155 |
3.5.3.18 | more |
dimerization is not critical for the maintenance of the biological function of the protein |
652942 |
3.5.3.18 | medicine |
endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine (hydrolyzed by DDAH) is elevated in many patients and may contribute to the initiation and progression of their disease |
667159 |
3.5.3.18 | medicine |
epoetin beta and darbepoetin alpha posttranslationally impair DDAH activity via increased oxidative stress, causing NG,NG-dimethyl-L-arginine as an important cardiovascular risk factor to accumulate and inhibit NO-synthesis |
669059 |
3.5.3.18 | medicine |
expression and secretion of the vascular endothelial growth factor is not increased in DDAH1-transfected cells |
667355 |
3.5.3.18 | medicine |
global knockout of Ddah2 results in elevated blood pressure during periods of activity and changes in vascular responsiveness mediated by changes in methylarginine concentration, and systemic nitric oxide concentrations. In a model of severe polymicrobial sepsis, Ddah2 knockout affects outcome. Monocyte-specific deletion of Ddah2 results in a similar pattern of increased severity to that seen in globally deficient animals |
752613 |